Upcoming events on Ampliphi Biosciences Corp

2025-03-12 Q4 2024 Earnings Release (Projected)
2025-05-07 Q1 2025 Earnings Release (Projected)
2025-08-12 Q2 2025 Earnings Release (Projected)
2025-11-17 Q3 2025 Earnings Release (Projected)

Past events on Ampliphi Biosciences Corp

2024-11-19 01:15 pm Phage Futures Congress
2024-11-13 04:05 pm Q3 2024 Earnings Release
2024-09-11 08:00 am H.C. Wainwright Global Investment Conference
2024-08-27 10:00 am Military Health System Research Symposium
2024-08-13 04:05 pm Q2 2024 Earnings Release
2024-07-17 09:20 pm Viruses of Microbes Conference
2024-06-11 Annual General Meeting
2024-05-07 04:01 pm Q1 2024 Earnings Release
2024-03-21 04:05 pm Q4 2023 Earnings Release
2024-02-28 12:00 pm Bacteriophage Therapy Summit
2023-11-14 04:00 pm Q3 2023 Earnings Release
2023-11-03 05:00 pm North American Cystic Fibrosis Conference (
2023-10-25 09:10 am Phage Futures: Global Digital Summit
2023-09-26 02:45 pm Cantor Global Healthcare Conference
2023-09-13 Annual General Meeting
2023-08-14 07:00 am Q2 2023 Earnings Release
2023-06-02 04:50 pm World Targeting Phage Therapy Conference
2023-05-11 04:05 pm Q1 2023 Earnings Release
2023-03-16 04:10 pm Q4 2022 Earnings Release
2022-11-30 10:00 am H.C. Wainwright Investor Conference

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024 2025
Net sales
Million USD
Released
Forecast
Spread
4,47
4,46
0.37%
5,51
6,13
-10.11%
4,53
3,87
17.01%

5,50


5,50

EBITDA
Million USD
Released
Forecast
Spread
-22,7
-26,3
13.87%
-36,1
-35,5
-1.56%
-39,9
-42,5
6.08%

-44,1


-50,6

EBIT
Million USD
Released
Forecast
Spread
-23,8
-24,9
4.17%
-36,9
-37,4
1.33%
-40,9
-44,9
8.85%

-44,1


-50,6

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-23,2
-24,2
4.51%
-36,9
-36,6
-0.91%
-69,0
-62,0
-11.39%

-34,8


-68,6

Net income
Million USD
Released
Forecast
Spread
-23,2
-24,2
4.51%
-36,9
-36,6
-0.91%
-69,0
-62,0
-11.39%

-34,8


-68,6

EPS
USD
Released
Forecast
Spread
-0,96
-1,01
4.95%
-1,08
-1,07
-1.41%
-1,91
-1,71
-12.02%

-0,95


-1,70

Announcement Date17/03/2216/03/2321/03/24-

Quarterly results

Fiscal PeriodSeptember 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,80
1,78
-55.26%
0,98
1,81
-45.84%
1,23
0,95
28.34%
1,53
0,86
77.67%
0,97
1,14
-14.93%
0,00
1,14
-
2,97
0,90
230.33%

1,56

EBITDA
Million USD
Released
Forecast
Spread
-11,1
-10,4
-6.88%
-9,40
-11,5
18.25%
-10,1
-11,6
12.8%
-9,29
-11,2
17.09%
-9,91
-10,2
2.83%
-11,6
-10,9
-6.41%
-9,44
-12,3
23.23%

-12,2

EBIT
Million USD
Released
Forecast
Spread
-11,3
-12,9
12.36%
-9,63
-14,4
32.92%
-10,3
-10,5
1.94%
-9,58
-11,5
16.37%
-10,2
-10,9
6.14%
-11,9
-11,4
-4.22%






Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-14,5
-11,5
-25.53%
-3,55
-13,4
73.57%
-31,2
-11,3
-175.6%
-19,8
-12,8
-55.24%
-25,0
-11,2
-123.48%
8,99
-16,0
156.18%
-5,48
-10,6
48.29%

-13,3

Net income
Million USD
Released
Forecast
Spread
-14,5
-11,5
-25.53%
-3,55
-13,4
73.57%
-31,2
-11,3
-175.6%
-19,8
-12,8
-55.24%
-25,0
-11,2
-123.48%
8,99
-16,0
156.18%
-5,48
-10,6
48.29%

-13,3

EPS
USD
Released
Forecast
Spread
-0,40
-0,32
-25%
-0,10
-0,38
73.33%
-0,86
-0,31
-177.42%
-0,55
-0,35
-57.14%
-0,69
-0,31
-122.58%
0,25
-0,44
156.82%
-0,15
-0,28
46.43%

-0,35

Announcement Date11/05/2314/08/2314/11/2321/03/2407/05/2413/08/2413/11/24-
  1. Stock Market
  2. Equities
  3. ARMP Stock
  4. APHB Stock
  5. Calendar Ampliphi Biosciences Corp